Thomas A Lutz Selected Research

Thomas A Lutz Research Topics

Disease

49	Body Weight (Weight, Body) 04/2024 - 05/2004
29	Obesity 09/2023 - 09/2008
20	Weight Loss (Weight Reduction) 04/2024 - 05/2010
15	AIDS-Related Complex (ARC) 01/2022 - 05/2003
12	Diabetes Mellitus 11/2020 - 11/2006
11	Anorexia 02/2024 - 11/2007
6	Type 2 Diabetes Mellitus (MODY) 10/2023 - 01/2014
5	Insulin Resistance 04/2022 - 04/2009
5	Hyperglycemia 03/2020 - 11/2010
5	Neoplasms (Cancer) 01/2018 - 11/2007
4	Metabolic Diseases (Metabolic Disease) 11/2022 - 12/2017
4	Hypoxia (Hypoxemia) 01/2020 - 03/2013
4	Morbid Obesity 01/2019 - 10/2011
4	Cachexia 01/2018 - 01/2016
3	Inflammation (Inflammations) 09/2023 - 03/2020
3	Overweight 09/2023 - 09/2010
3	Amyloid Plaque 01/2022 - 01/2015
3	Acromegaly 05/2021 - 10/2017
3	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 05/2003
2	Migraine Disorders (Migraine) 12/2022 - 01/2022
2	Nausea 01/2022 - 01/2018
2	Glucose Intolerance 01/2020 - 09/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2019 - 10/2018
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2018 - 10/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2018 - 01/2016
1	Body-Weight Trajectory 04/2024
1	Endocrine System Diseases (Endocrine Diseases) 04/2022
1	Hypersensitivity (Allergy) 01/2022
1	Lung Diseases (Lung Disease) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Stroke (Strokes) 01/2022
1	Sepsis (Septicemia) 01/2022
1	Ischemic Stroke 01/2022
1	Vomiting 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Weight Gain 05/2021
1	Gliosis 01/2021
1	Feeding and Eating Disorders (Eating Disorder) 10/2020

Drug/Important Bio-Agent (IBA)

39	Islet Amyloid PolypeptideIBA 02/2024 - 03/2005
22	LeptinIBA 01/2022 - 05/2003
19	Glucose (Dextrose)FDA LinkGeneric 10/2023 - 07/2006
17	Insulin (Novolin)FDA Link 10/2023 - 07/2006
15	Hormones (Hormone)IBA 01/2022 - 05/2003
10	salicylhydroxamic acid (SHAM)IBA 04/2024 - 05/2010
9	Peptides (Polypeptides)IBA 09/2023 - 05/2003
9	Appetite Depressants (Anorectics)IBA 09/2023 - 05/2003
9	GhrelinIBA 05/2017 - 05/2003
6	Blood Glucose (Blood Sugar)IBA 10/2023 - 01/2009
6	Islet Amyloid Polypeptide ReceptorsIBA 04/2022 - 01/2010
6	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2020 - 04/2010
6	LipidsIBA 12/2019 - 08/2010
5	CytokinesIBA 09/2023 - 10/2014
5	Messenger RNA (mRNA)IBA 09/2023 - 10/2014
5	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 01/2020 - 05/2003
4	Glucagon (Glukagon)FDA Link 11/2022 - 11/2006
4	Calcitonin Receptors (Calcitonin Receptor)IBA 04/2022 - 02/2016
4	Ghrelin ReceptorsIBA 12/2017 - 05/2003
4	Interleukin-6 (Interleukin 6)IBA 05/2017 - 10/2014
4	Neuropeptide YIBA 12/2016 - 01/2009
3	Proteins (Proteins, Gene)FDA Link 03/2020 - 10/2014
3	CholesterolIBA 11/2019 - 01/2015
2	Calcitonin Gene-Related PeptideIBA 12/2022 - 01/2022
2	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 04/2022 - 01/2020
2	Amylin Receptor AgonistsIBA 04/2021 - 07/2015
2	Apolipoproteins E (ApoE)IBA 12/2019 - 10/2018
2	Lipoproteins (Lipoprotein)IBA 12/2019 - 01/2016
2	AdipokinesIBA 10/2018 - 03/2016
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 09/2018 - 10/2017
2	AP-102IBA 09/2018 - 10/2017
2	Leptin ReceptorsIBA 01/2018 - 03/2016
2	HM01IBA 05/2017 - 01/2016
2	Estradiol (Delestrogen)FDA LinkGeneric 03/2016 - 08/2012
2	Amyloid (Amyloid Fibrils)IBA 01/2015 - 03/2010
2	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 08/2012 - 11/2010
2	LipopolysaccharidesIBA 08/2012 - 11/2010
2	Cholecystokinin (Pancreozymin)IBA 08/2012 - 11/2011
1	Sucrose (Saccharose)IBA 04/2024
1	Glucagon-Like Peptide ReceptorsIBA 09/2023
1	Glucagon-Like Peptides (Enteroglucagon)IBA 09/2023
1	Insulin SecretagoguesIBA 09/2023
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2023
1	ResistinIBA 09/2023
1	AdiponectinIBA 09/2023
1	Amino Acids FDA Link 11/2022
1	Glucagon Receptors (Glucagon Receptor)IBA 11/2022
1	Tamoxifen FDA LinkGeneric 01/2022
1	Volatile Fatty AcidsIBA 01/2022
1	trimethyloxamine (trimethylamine N-oxide)IBA 01/2022
1	pyrrolidonyl-beta-naphthylamideIBA 01/2022
1	Insulin-Like PeptidesIBA 05/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 05/2021
1	Receptor Activity-Modifying ProteinsIBA 01/2021
1	salmon calcitonin (Calcimar)FDA LinkGeneric 01/2021
1	pegylated leptinIBA 01/2021

Therapy/Procedure

16	Gastric Bypass (Roux-en-Y Gastric Bypass) 04/2024 - 05/2010
13	Therapeutics 12/2022 - 09/2008
5	Bariatric Surgery 02/2015 - 06/2012
3	Glycemic Control 09/2023 - 07/2014
3	Drug Therapy (Chemotherapy) 04/2022 - 10/2020
2	Injections 07/2011 - 11/2010